Neuronetics Q2 Earnings Call Highlights

Neuronetics reported strong Q2 2026 financial performance, with revenue climbing 9.1% to $41.6 million. The company also achieved a significantly reduced net loss and positive adjusted EBITDA, driven by its Greenbrook clinic operations.
Key takeaways
- Revenue increased 9.1% to $41.6 million in Q2 2026.
- Net loss narrowed considerably compared to the previous year.
- Positive adjusted EBITDA achieved, signaling operational profitability.
- Growth driven by Greenbrook clinic business segment.
Why it matters
This financial improvement for Neuronetics, a company focused on neurostimulation, indicates growing market adoption and operational efficiency. For AI users, it suggests potential for increased investment and development in AI-driven healthcare solutions, impacting future tool availability and capabilities.
Try this on SynaBot
Related AI assistants, prompts, and tools from the SynaBot catalog.
- RecallRecall is an AI video tool that helps users summarize and repurpose long-form video content into short-form clips, scripts, storyboards, and captions.
- AI Testimonial GeneratorThis AI tool generates authentic-sounding customer testimonials based on product features and target audience. It helps businesses quickly gather social proof for marketing efforts.
- KrispCallKrispCall is a cloud telephony system that integrates AI for intelligent call management features. It offers call recording, analytics, and virtual numbers, enhancing communication for businesses of all sizes.



